Delta Corp operates luxury offshore and land-based casinos in Goa and Sikkim, providing gaming tables and slot machines alongside premium hotel accommodations to domestic tourists.
The company benefits from high regulatory barriers to entry due to a limited number of offshore casino licenses in Goa. However, the lack of pricing power is evident as margins contracted significantly following GST hikes, and the business remains highly sensitive to tax policy shifts.
Management has pivoted from online gaming to real estate and hospitality demergers. While the exit from online gaming provided a one-time gain, the aggressive move into real estate and theme parks represents a shift away from their core competency and high-margin gaming roots.
The investment collapsed because the regulatory sword finally fell. The retrospective tax demand, which dwarfed the company's entire valuation, was upheld in court, forcing a fire sale of assets and massive dilution. Meanwhile, management's pivot into unrelated real estate and theme parks drained remaining cash reserves into low-return projects outside their core competency. The core gaming business, already suffering from margin compression due to tax hikes, became a stagnant utility-like operation incapable of outearning its cost of capital.
RichFakir rates Delta Corp Ltd's business quality as poor — 36/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as narrow.
On our model, Delta Corp Ltd is trading about 45% above our estimate of fair value; we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Delta Corp Ltd is: Not rated. A poor business at an expensive price — it does not make our shortlist right now. We marked it down a notch: revenue and earnings barely grow — a steady cash cow, not a compounder.
RichFakir's educational estimate of Delta Corp Ltd's fair value is about ₹51 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →